Zhang M, Han Z, Lin Y, Jin Z, Zhou S, Wang S
Front Microbiol. 2024; 15:1418301.
PMID: 39006752
PMC: 11239345.
DOI: 10.3389/fmicb.2024.1418301.
Pereira J, Ikegami R, Kawakami J, Garavelo S, Reis M, Palomino S
Front Cell Infect Microbiol. 2021; 11:732276.
PMID: 34912727
PMC: 8668412.
DOI: 10.3389/fcimb.2021.732276.
Makvandi M, Azaran A, Jalilian S, Parsa Nahad M, Azizolahi B, Neisi N
Iran J Microbiol. 2021; 13(5):703-711.
PMID: 34900168
PMC: 8629818.
DOI: 10.18502/ijm.v13i5.7437.
Scudiero F, Valenti R, Marcucci R, Sanna G, Gori A, Migliorini A
J Am Heart Assoc. 2020; 9(18):e016441.
PMID: 32885738
PMC: 7726996.
DOI: 10.1161/JAHA.120.016441.
Hussein A, Abdel Ghany M, Mahmoud H
Egypt Heart J. 2020; 72(1):44.
PMID: 32712829
PMC: 7382666.
DOI: 10.1186/s43044-020-00079-9.
HCV Extrahepatic Manifestations.
Kuna L, Jakab J, Smolic R, Wu G, Smolic M
J Clin Transl Hepatol. 2019; 7(2):172-182.
PMID: 31293918
PMC: 6609844.
DOI: 10.14218/JCTH.2018.00049.
Carotid Intima-media Thickness and Small Dense Low-density Lipoprotein Cholesterol Increase after One Year of Treatment with Direct-acting Antivirals in Patients with Hepatitis C Virus Infection.
Ichikawa T, Miyaaki H, Miuma S, Motoyoshi Y, Narita S, Toda S
Intern Med. 2019; 58(9):1209-1215.
PMID: 30626818
PMC: 6543209.
DOI: 10.2169/internalmedicine.1514-18.
Hepatitis C virus and the kidney.
Pol S, Parlati L, Jadoul M
Nat Rev Nephrol. 2018; 15(2):73-86.
PMID: 30455426
DOI: 10.1038/s41581-018-0081-8.
Atherosclerosis in chronic hepatitis C virus patients with and without liver cirrhosis.
Barakat A, Nasr F, Metwaly A, Morsy S, Eldamarawy M
Egypt Heart J. 2018; 69(2):139-147.
PMID: 29622968
PMC: 5839344.
DOI: 10.1016/j.ehj.2016.10.004.
Impact of hepatitis C virus infection on long-term mortality after acute myocardial infarction: a nationwide population-based, propensity-matched cohort study in Taiwan.
Kuo S, Hung W, Tang P, Huang W, Yang J, Lin H
BMJ Open. 2018; 8(1):e017412.
PMID: 29374659
PMC: 5829782.
DOI: 10.1136/bmjopen-2017-017412.
Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications.
Marra F, Honer Zu Siederdissen C, Khoo S, Back D, Schlag M, Ouwerkerk-Mahadevan S
Br J Clin Pharmacol. 2018; 84(5):961-971.
PMID: 29345798
PMC: 5903235.
DOI: 10.1111/bcp.13519.
Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review.
Babiker A, Jeudy J, Kligerman S, Khambaty M, Shah A, Bagchi S
J Clin Transl Hepatol. 2017; 5(4):343-362.
PMID: 29226101
PMC: 5719192.
DOI: 10.14218/JCTH.2017.00021.
Extrahepatic manifestations of chronic hepatitis C virus infection.
Cacoub P, Comarmond C, Domont F, Savey L, Desbois A, Saadoun D
Ther Adv Infect Dis. 2016; 3(1):3-14.
PMID: 26862398
PMC: 4735500.
DOI: 10.1177/2049936115585942.
Higher Prevalence and More Severe Coronary Artery Disease in Hepatitis C Virus-infected Patients: A Case Control Study.
Satapathy S, Kim Y, Kataria A, Shifteh A, Bhansali R, Cerulli M
J Clin Exp Hepatol. 2015; 3(3):186-91.
PMID: 25755499
PMC: 3940268.
DOI: 10.1016/j.jceh.2013.05.004.
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.
Adinolfi L, Nevola R, Lus G, Restivo L, Guerrera B, Romano C
World J Gastroenterol. 2015; 21(8):2269-80.
PMID: 25741133
PMC: 4342902.
DOI: 10.3748/wjg.v21.i8.2269.
Atherosclerosis as a possible extrahepatic manifestation of chronic hepatitis C virus infection.
Ishizaka N, Ishizaka Y, Yamkado M
Clin Med Insights Cardiol. 2014; 8(Suppl 3):1-5.
PMID: 25452704
PMC: 4230236.
DOI: 10.4137/CMC.S17069.
Impact of hepatitis C seropositivity on the risk of coronary heart disease events.
Pothineni N, Delongchamp R, Vallurupalli S, Ding Z, Dai Y, Hagedorn C
Am J Cardiol. 2014; 114(12):1841-5.
PMID: 25438910
PMC: 4372470.
DOI: 10.1016/j.amjcard.2014.09.020.
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.
Antonelli A, Ferrari S, Giuggioli D, Di Domenicantonio A, Ruffilli I, Corrado A
World J Diabetes. 2014; 5(5):586-600.
PMID: 25317237
PMC: 4138583.
DOI: 10.4239/wjd.v5.i5.586.
Is hepatitis C associated with atherosclerotic burden? A systematic review and meta-analysis.
Huang H, Kang R, Zhao Z
PLoS One. 2014; 9(9):e106376.
PMID: 25184517
PMC: 4153605.
DOI: 10.1371/journal.pone.0106376.
Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature.
Wong R, Kanwal F, Younossi Z, Ahmed A
Dig Dis Sci. 2014; 59(7):1586-93.
PMID: 24894512
DOI: 10.1007/s10620-014-3222-3.
